Continuous Versus Intermittent Administration of Meropenem in Critically Ill Patients

Ther Drug Monit. 2024 Oct 1;46(5):692-693. doi: 10.1097/FTD.0000000000001181. Epub 2024 Jun 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents* / administration & dosage
  • Anti-Bacterial Agents* / pharmacokinetics
  • Anti-Bacterial Agents* / therapeutic use
  • Critical Illness* / therapy
  • Drug Administration Schedule
  • Humans
  • Meropenem* / administration & dosage
  • Meropenem* / pharmacokinetics
  • Meropenem* / therapeutic use

Substances

  • Meropenem
  • Anti-Bacterial Agents